Abstract:Objective: To identify simple, contemporary predictors of both morbidity and mortality in pediatric patients with purpuric sepsis syndrome in order to provide a basis for future study of innovative interventions. Design: Retrospective study. Setting: An 18-bed multidisciplinary intensive care unit (ICU) in a large pediatric hospital. Patients: A total of 53 patients, ranging in age from 18 days to 17 yrs (mean 4.9 yrs) with either culture-proven meningococcal sepsis or the systemic inflammatory response syndrome with purpura, who were admitted to the ICU during the period from January 1, 1982 through March 15, 1992. Methods: A computerized database was constructed containing the characteristics of these patients at presentation, during the first 24 hrs of hospitalization, and on discharge. Single variables were screened for significance between "good" (intact survival) and "poor" (mortality or survival with significant morbidity) outcome groups. Those variables found to be most significant were then tested for sensitivity, specificity, and predictive value. The best predictors identified in this manner were then compared with the two most-cited prognosticating strategies as applied to these patients. Measurements and main results: Coagulopathy (defined as a partial thromboplastin time > 50 secs or serum fibrinogen concentration < 150 mg/dL [4.4 mumol/L]) at the referral site or on ICU admission was identified as an excellent predictor of poor outcome: sensitivity, specificity, positive and negative predictive values of a low serum fibrinogen value, being 81%, 95%, 93%, and 88%, and of prolonged partial thromboplastin time, being 95%, 90%, 86%, and 97%, respectively. Classical prognosticating strategies were found to be inadequately associated with mortality, yet comparable with coagulopathy in identifying patients destined for clinically important morbidity. Conclusions: We conclude that: a) outcome of pediatric patients with meningococcal sepsis or the systemic inflammatory response syndrome with purpura can be predicted rapidly, more easily, and with overall accuracy superior to classical prognostication strategies by the simple presence or absence of coagulopathy; b) when applied to a contemporary population, classical prognostication strategies lack value for prediction of mortality, yet remain valid for prediction of "poor outcome" (significant morbidity + mortality); c) when evaluating treatment strategies for such patients, the presence of serious coagulopathy may potentially be useful as an index of illness severity.

Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia

Treatment of purpura fulminans in meningococcemia with protein C concentrate

Therapeutic plasma exchange in critically ill children: 18-year experience of a tertiary care paediatric intensive care unit

Local Experience With Extracorporeal Membrane Oxygentaion In Children With Acute Fulminant Myocarditis

The clinical application of plasma exchange therapy in critically ill children

Evaluation of patients undergoing therapeutic plasma exchange in the pediatric intensive care unit and determining the factors affecting prognosis

An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia

Extracorporeal membrane oxygenation for the treatment of children with severe hemodynamic alteration in perioperative cardiovascular surgery

Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study

Clinical Application of Extracorporeal Membrane Oxygenation in Children with Refractory Cardiopulmonary Failure

[Emergency Use of Extracorporeal Membrane Oxygenation in Pediatric Critically Ill Patients].

Therapeutic Plasma Exchange in Pediatric Intensive Care Unit: A Single-center Experience

Evaluation of the results of the patients who underwent plasmapheresis in the pediatric intensive care unit

Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study

Therapeutic plasma exchange as treatment modality in pediatric patients with neurologic and nonneurologic diseases at the Philippine Children's Medical Center: A 12‐year single center experience

Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura

The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis

Mechanical support for the treatment of fulminant myocarditis combined with cardiac arrest and MODS in children: A case report and review

[Hemoperfusion and plasmapheresis in the intensive care unit]

Prophylactic Transfusion Strategies in Children Supported by Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference

[Intrapleural urokinase in the treatment of parapneumonic effusions]